🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

AI System for Anatomic Recognition & Lesion Detection in Nasopharyngolaryngoscopy: A Prospective Study

Recruitingn/aAges 18 Years - anyAllRuijin Hospital
NCT07326358 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

An artificial intelligence-assisted system is trained and validated by collecting nasopharyngolaryngoscopy images from patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 18 years; * Underwent standard electronic nasopharyngolaryngoscopy; * Patients who underwent biopsy sampling have a clear pathological diagnosis; * Signed a written informed consent form. Exclusion Criteria: * Image quality is substandard with severe motion artifacts; * Lesion images are unclear and incomplete.
💊

What it tests

  • Diagnostic
  • Diagnostic
📍

Where

1 site
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy